Revolution's Daraxonrasib: A Promising Advance in Pancreatic Cancer Treatment
Revolution Medicines' Daraxonrasib shows great promise for metastatic pancreatic cancer, targeting RAS mutations. It works well in both new and previously treated patients, alone or with chemo, with good safety. Big trials are planned to make it a new standard of care.